Astec LifeSciences ends at 2% premium on BSE

Image
Press Trust of India Mumbai
Last Updated : Jan 20 2013 | 12:21 AM IST

The stock ended at Rs 84 - up 2.3% from its issue price. the counter witnessed hefty volumes of 12.26 million shares on BSE today.
______________________________________________
(Updated at 1139 hrs)

Agro-chemical and pharma company Astec LifeSciences today got listed at a premium of 4.33 per cent over its issue price of Rs 82 on the Bombay Stock Exchange.

In early trade today, the scrip opened at Rs 85.55 and surged 10.61 per cent to a high of Rs 90.70 within minutes of opening on the BSE.

The company listed over 1.69 crore shares on the bourses at an issue price of Rs 82 a piece.

On the National Stock Exchange Astec LifeSciences got listed at Rs 83, a 1.22 per cent premium over its issue price. It later scaled to a high of Rs 90.70 on the bourse.

Over 77.51 lakh shares changed hands on both the bourses.

The company raised over Rs 61 crore through an initial public offer (IPO) earlier this month which it plans to utilise for funding its expansion plans.

Astec LifeSciences is engaged in the manufacturing and sale of intermediates, active ingredients and formulations with a focus on agrochemical and pharmaceutical industry.

The scrip was later quoting at Rs 86.15, up 5.06 per cent on the BSE and with a gain of 4.87 per cent at Rs 86 on the NSE at 1026 hrs.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 25 2009 | 4:15 PM IST

Next Story